Loading...
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase.
Stefanachi, Angela ; Hanke, Nina ; Pisani, Leonardo ; Leonetti, Francesco ; Nicolotti, Orazio ; Catto, Marco ; Cellamare, Saverio ; Hartmann, Rolf W ; Carotti, Angelo
Stefanachi, Angela
Hanke, Nina
Pisani, Leonardo
Leonetti, Francesco
Nicolotti, Orazio
Catto, Marco
Cellamare, Saverio
Hartmann, Rolf W
Carotti, Angelo
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2015-01-07
Submitted date
Files
Loading...
original manuscript
Adobe PDF, 820.62 KB
Loading...
Table 1
Adobe PDF, 57.6 KB
Loading...
Table 2
Adobe PDF, 105.87 KB
Loading...
Table 3
Adobe PDF, 54.07 KB
Other Titles
Abstract
Diseases triggered by an abnormally high level of cortisol (hypercortisolism), such as the Cushing's and metabolic syndromes, could be successfully tackled by inhibitors of CYP11B1, a steroidal cytochrome P450 enzyme that catalyzes the last hydroxylation step of the cortisol biosynthesis. Structural optimization of 7-(benzyloxy)-4-(1H-imidazol-1-ylmethyl)-2H-chromen-2-one 2, a selective aromatase inhibitor, afforded the 4-(1H-imidazol-1-ylmethyl)-7-{[3-(trifluoromethoxy)benzyl]oxy}-2H-chromen-2-one 7, with improved inhibitory potency at human CYP11B1 (IC50 = 5 nM) and an enhanced selectivity over human CYP11B2 (SIB = 25) compared to lead compound 2 (IC50 = 72 nM, SIB = 4.0) and metyrapone (IC50 = 15 nM, SIB = 4.8), a non-selective drug used in the therapy of the Cushing's syndrome. Structure-activity relationship studies allowed the design and optimization of a novel series of potent and selective compounds, that can be regarded as open analogues of 2H-chromen-2-one derivatives. Compound 23, 2-(1H-imidazol-1-yl)-1-(4-{[3(trifluoromethoxy)benzyl]oxy}phenyl) ethanone, was the most interesting inhibitor of the series displaying a high potency at CYP11B1 (IC50 = 15 nM), increased selectivities over CYP11B2 (SIB = 33), CYP19 (SIB = 390) and CYP17 (5% inhibition at 2.5 μM concentration).
Citation
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase. 2015, 89:106-14 Eur J Med Chem
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1768-3254
